Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2[...]
01/20/2022 | Press release | Distributed by Public on 01/20/2022 09:01
Please select the service you want to use:
Smartlinks | Core & Main Inc. | News | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Business Announcement | Public Companies | Industrial Equipment and Components Manufacturers | New York Stock Exchange (NYSE) | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact